Mickey S. Urdea
14Patents
11h-index
25Co-inventors
72Inventor score
Filing activity: Jun 20, 1983 → May 5, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4868105A | Solution phase nucleic acid sandwich assay | Emerging Cross-Sectional Technologies | 228 | Expired |
| US4775619A | Polynucleotide determination with selectable cleavage sites | Emerging Cross-Sectional Technologies | 211 | Expired |
| US4517338A | Multiple reactor system and method for polynucleotide synthesis | Emerging Cross-Sectional Technologies | 155 | Expired |
| US4483964A | Reactor system and method for polynucleotide synthesis | Emerging Cross-Sectional Technologies | 51 | Expired |
| US5612041A | Recombinant herpes simplex gD vaccine | Chemistry; Metallurgy | 42 | Expired |
| US5096825A | Gene for human epidermal growth factor and synthesis and expression thereof | Chemistry; Metallurgy | 40 | Expired |
| US4618578A | Expression of glycoprotein D of herpes simplex virus | Emerging Cross-Sectional Technologies | 28 | Expired |
| US4914026A | Alpha factor leader sequence directed secretion of insulin | Chemistry; Metallurgy | 23 | Expired |
| US5015575A | Hybrid DNA synthesis of insulin | Chemistry; Metallurgy | 21 | Expired |
| US7981930B2 | Compositions and kits for treating influenza | Human Necessities | 19 | Active |
| US7858660B2 | Compositions and kits for treating influenza | Human Necessities | 18 | Active |
| US9057736B2 | Markers associated with arteriovascular events and methods of use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US9689880B2 | Markers associated with arteriovascular events and methods of use thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US8021839B2 | Methods and compositions for detecting polynucleotides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.